Literature DB >> 26131281

Evaluation of photodynamic therapy using topical aminolevulinic acid hydrochloride in the treatment of condylomata acuminate.

Zhen Zhang1, Xiao-Nian Lu1, Jun Liang1, Hui Tang1, Yong-Sheng Yang1, Xiao-Hua Zhu1, Juan Du1, Yan-Yun Shen1, Jin-Hua Xu1.   

Abstract

OBJECTIVES: To investigate the efficacy and safety of topical application of 5-aminolaevulinic acid (ALA) photodynamic therapy (PDT) for the treatment of condylomata acuminata (CA) in larger population.
METHODS: Patients with CA were given a treatment of ALA-PDT once a week for 3 weeks and followed up at 4, 8, 12 and 24 weeks after the treatment finished.
RESULTS: In 531 patients, a clearance rate was observed 95.27%. The rates rouse with PDT cycles. The clearance rate of three PDT cycles was significant higher than one PDT cycles (P < 0.001) and two PDT cycles (P < 0.001). The clearance rate (88.73%) of small lesions (diameter small than 5mm) was significant higher than that (97.74%) of larger lesions (P < 0.001). The clearance rate varied with the location of the lesions. The clearance rate of urethral meatus was highest and that of perianal was lowest. Follow-up for patients with complete response lasted for 24 weeks. The recurrence rate was 5.65%, 11.30%, 15.07%, 15.44% and 16.20% after 1, 4, 8, 12 and 24 weeks. The recurrence rate varied with the location of the lesions. The recurrence rate of perianal was highest and that of labium was lowest. The side effects mainly included flare, pain, erosion, ulcer, and hyperpigmentation. The adverse reaction rate was 7.72%, 8.10%, 2.26%, 0.94% and 0.19%. Sexual dysfunction and urethral malformations were not observed during the 24 weeds visit.
CONCLUSION: Topical application of ALA-PDT is a simple and as effective therapy with a lower incidence of adverse effects in the treatment of condylomata acuminata.

Entities:  

Keywords:  Clearance rate; condylomata acuminate; photodynamic therapy

Year:  2015        PMID: 26131281      PMCID: PMC4483838     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  12 in total

Review 1.  Aminolevulinic acid photodynamic therapy for skin cancers.

Authors:  Jonathan E Blume; Allan R Oseroff
Journal:  Dermatol Clin       Date:  2007-01       Impact factor: 3.478

Review 2.  Photodynamic therapy update 2007.

Authors:  Michael H Gold
Journal:  J Drugs Dermatol       Date:  2007-11       Impact factor: 2.114

Review 3.  Photodynamic therapy in dermatology--an update.

Authors:  Philipp Babilas; Sigrid Karrer; Alexis Sidoroff; Michael Landthaler; Rolf-Markus Szeimies
Journal:  Photodermatol Photoimmunol Photomed       Date:  2005-06       Impact factor: 3.135

4.  Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment.

Authors:  E V Ross; R Romero; N Kollias; C Crum; R R Anderson
Journal:  Br J Dermatol       Date:  1997-11       Impact factor: 9.302

5.  Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata.

Authors:  X L Wang; H W Wang; H S Wang; S Z Xu; K H Liao; P Hillemanns
Journal:  Br J Dermatol       Date:  2004-10       Impact factor: 9.302

6.  Recurrence of condylomata acuminata of the urethra after conventional and fluorescence-controlled Nd:YAG laser treatment.

Authors:  D Zaak; A Hofstetter; D Frimberger; P Schneede
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

7.  Evaluation of photodynamic therapy using topical aminolevulinic acid hydrochloride in the treatment of condylomata acuminata: a comparative, randomized clinical trial.

Authors:  Jun Liang; Xiao Nian Lu; Hui Tang; Zhen Zhang; Jing Fan; Jin Hua Xu
Journal:  Photodermatol Photoimmunol Photomed       Date:  2009-12       Impact factor: 3.135

8.  In vivo fluorescence kinetics and photodynamic therapy in condylomata acuminata.

Authors:  I M Stefanaki; S Georgiou; G C Themelis; E M Vazgiouraki; A D Tosca
Journal:  Br J Dermatol       Date:  2003-11       Impact factor: 9.302

9.  In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy.

Authors:  Mark J Niedre; Andrea J Secord; Michael S Patterson; Brian C Wilson
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

10.  Study of protoporphyrin IX (PpIX) pharmacokinetics after topical application of 5-aminolevulinic acid in urethral condylomata acuminata.

Authors:  Xiu-Li Wang; Hong-Wei Wang; Zheng Huang; Herbert Stepp; Reinhold Baumgartner; Christian Dannecker; Peter Hillemanns
Journal:  Photochem Photobiol       Date:  2007 Sep-Oct       Impact factor: 3.421

View more
  5 in total

1.  Infections after photodynamic therapy in Condyloma acuminatum patients: incidence and management.

Authors:  Xin Yu; Heyi Zheng
Journal:  Environ Sci Pollut Res Int       Date:  2018-03-07       Impact factor: 4.223

2.  Photodynamic therapy inhibit Fibroblast Growth Factor-10 induced keratinocyte differentiation and proliferation through ROS in Fibroblast Growth Factor Receptor-2b pathway.

Authors:  Maya Valeska Gozali; Fei Yi; Jia-An Zhang; Juan Liu; Hong-Jin Wu; Yang Xu; Dan Luo; Bing-Rong Zhou
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

3.  Efficacy and safety of combined high-dose interferon and red light therapy for the treatment of human papillomavirus and associated vaginitis and cervicitis: A prospective and randomized clinical study.

Authors:  Hui-Juan Shi; Hongbin Song; Qian-Ying Zhao; Chun-Xia Tao; Min Liu; Qin-Qin Zhu
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 4.  Tissue Engineering and Photodynamic Therapy: A New Frontier of Science for Clinical Application -An Up-To-Date Review.

Authors:  Mariza Aires-Fernandes; Camila Fernanda Amantino; Stéphanie Rochetti do Amaral; Fernando Lucas Primo
Journal:  Front Bioeng Biotechnol       Date:  2022-06-15

5.  Management of a giant perineal condylomata acuminata.

Authors:  Evelyn Hemper; Mathias Wittau; Johannes Lemke; Marko Kornmann; Doris Henne-Bruns
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2016-01-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.